Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Methylation Regulation Mechanism of Blood Stasis Relevant miRNA Expression on Coronary Heart Disease

NCT03083119 is registered in ClinicalTrials.gov with Jie Wang as lead sponsor.

NCT NCT03083119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03083119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Methylation Regulation Mechanism of Blood Stasis Relevant miRNA Expression on Coronary Heart Disease
Lead sponsor
Jie Wang
Phase
Phase 2
Overall status
Unknown status
Start date
March 20, 2017
Completion date
August 20, 2017
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, unstable angina